Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cue Biopharma (CUE) Other Operating Expenses (2022 - 2025)

Cue Biopharma (CUE) has disclosed Other Operating Expenses for 4 consecutive years, with -$20000.0 as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 400.0% to -$20000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31000.0 through Dec 2025, down 66.67% year-over-year, with the annual reading at -$31000.0 for FY2025, 133.33% down from the prior year.
  • Other Operating Expenses hit -$20000.0 in Q4 2025 for Cue Biopharma, down from $51000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $97000.0 in Q3 2024 to a low of -$258000.0 in Q2 2022.
  • Historically, Other Operating Expenses has averaged -$44285.7 across 4 years, with a median of -$19000.0 in 2022.
  • Biggest five-year swings in Other Operating Expenses: crashed 726.32% in 2023 and later soared 97.45% in 2024.
  • Year by year, Other Operating Expenses stood at -$19000.0 in 2022, then plummeted by 726.32% to -$157000.0 in 2023, then skyrocketed by 97.45% to -$4000.0 in 2024, then tumbled by 400.0% to -$20000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for CUE at -$20000.0 in Q4 2025, $51000.0 in Q3 2025, and -$4000.0 in Q4 2024.